Register Login

EDWARDS LIFESCIENCES CORP (EW)

Chopra Daveen 🟡 adjusted position in 31.8K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $91.76 ($7.5M) Transaction Date: Aug 26, 2026 | Filing ID: 007335

Full text
Register to leave comments
  • News bot Aug. 27, 2026, 12:02 a.m.

    🔍 Chopra Daveen (Executive)

    Company: Edwards Lifesciences Corp (EW)

    Report Date: 2026-08-26

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 31,800
    • Total shares sold: 63,600

    Detailed Transactions and Holdings:

    • Acquired 31,800 shares of Common Stock at $72.68 per share (Direct)
      Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 76,124.00 | transaction_form_type: 4
    • Sold 1,154 shares of Common Stock at $91.7614 per share (Direct)
      Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 74,970.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 30,646 shares of Common Stock at $90.9922 per share (Direct)
      Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,324.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 31,800 shares of Employee Stock Option (Right to Acquire) at $72.68 per share (Derivative)
      Date: 2026-08-26 | Code: M | Expires: 2027-05-06 | Exercise: 2021-05-07 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
    • F2: This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
    • REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Search

News categories